CCL5 and neoplasm: It was shown that the use of GD2.CAR-T cells and OVs armed with the chemokine RANTES and IL15 directly accelerated caspase pathways in tumor-exposed T cells, with RANTES and IL15 promoting CAR-T recruitment to the tumor and ensuring their local survival (305).